These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 9655154)

  • 21. [Influencing factors in the control of phosphorus in peritoneal dialysis. Therapeutic options].
    Gallar P; Ortega O; Gutiérrez M; Muñoz M; Hilara L; Oliet A; Rodríguez I; Giménez E; Vigil A
    Nefrologia; 2000; 20(4):355-61. PubMed ID: 11039261
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The requirement of low calcium dialysate in patients on continuous ambulatory peritoneal dialysis receiving calcium carbonate as a phosphate binder.
    Cheng IK; Lu HB; Chan CY; Cheng SW; Robinson JD; Tam SC; Lo WK; Cheung WC
    Clin Nephrol; 1993 Aug; 40(2):100-5. PubMed ID: 8222365
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Successful control of hyperparathyroidism in patients on continuous ambulatory peritoneal dialysis using magnesium carbonate and calcium carbonate as phosphate binders.
    Parsons V; Baldwin D; Moniz C; Marsden J; Ball E; Rifkin I
    Nephron; 1993; 63(4):379-83. PubMed ID: 8459870
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Renal osteodystrophy and aluminum bone disease in CAPD patients.
    Gokal R
    Clin Nephrol; 1988; 30 Suppl 1():S64-7. PubMed ID: 3052962
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Symptomatic hypercalcemia in a diabetic patient undergoing continuous ambulatory peritoneal dialysis: value of bone biopsy in the diagnosis and management.
    Frazao J; Coburn JW
    Am J Kidney Dis; 1995 Nov; 26(5):831-5. PubMed ID: 7485141
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-term effects on PTH and mineral metabolism of 1.25 versus 1.75 mmol/L dialysate calcium in peritoneal dialysis patients: a meta-analysis.
    Jin L; Zhou J; Shao F; Yang F
    BMC Nephrol; 2019 Jun; 20(1):213. PubMed ID: 31185931
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reduced calcium dialysate in CAPD patients: efficacy and limitations.
    Armstrong A; Beer J; Noonan K; Cunningham J
    Nephrol Dial Transplant; 1997 Jun; 12(6):1223-8. PubMed ID: 9198055
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Secondary hyperparathyroidism in diabetic and nondiabetic patients on long-term continuous ambulatory peritoneal dialysis (CAPD).
    Nilsson P; Danielson BG; Grefberg N; Wide L
    Scand J Urol Nephrol; 1985; 19(1):59-65. PubMed ID: 4023650
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reversibility of parathyroid gland suppression in CAPD patients with low i-PTH levels.
    Montenegro J; Saracho R; González O; Moina I; Martínez I
    Clin Nephrol; 1997 Dec; 48(6):359-63. PubMed ID: 9438094
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Relationship between the serum parathyroid hormone and magnesium levels in continuous ambulatory peritoneal dialysis (CAPD) patients using low-magnesium peritoneal dialysate.
    Cho MS; Lee KS; Lee YK; Ma SK; Ko JH; Kim SW; Kim NH; Choi KC
    Korean J Intern Med; 2002 Jun; 17(2):114-21. PubMed ID: 12164088
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Changes in mineral metabolism in stage 3, 4, and 5 chronic kidney disease (not on dialysis)].
    Lorenzo Sellares V; Torregrosa V
    Nefrologia; 2008; 28 Suppl 3():67-78. PubMed ID: 19018742
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hypercalcemia in patients treated with CAPD.
    Orłowska-Kowalik G; Ksiazek A
    Ann Univ Mariae Curie Sklodowska Med; 2004; 59(2):479-84. PubMed ID: 16146134
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Calcium-phosphate and parathyroid intradialytic profiles: A potential aid for tailoring the dialysate calcium content of patients on different hemodialysis schedules.
    Ferraresi M; Pia A; Guzzo G; Vigotti FN; Mongilardi E; Nazha M; Aroasio E; Gonella C; Avagnina P; Piccoli GB
    Hemodial Int; 2015 Oct; 19(4):572-82. PubMed ID: 25819092
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A randomized trial comparing 2.5 mEq/L calcium dialysate and calcitriol to 3.5 mEq/L calcium dialysate in patients on peritoneal dialysis.
    Banalagay E; Bernardini J; Holley J; Chen T; Piraino B
    Adv Perit Dial; 1993; 9():280-3. PubMed ID: 8105943
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Calcium balance during pulse alfacalcidol therapy for secondary hyperparathyroidism in CAPD patients treated with 1.0 and 1.25 mmol/L dialysate calcium.
    Chagnac A; Ori Y; Weinstein T; Herman M; Korzets A; Zevin D; Hirsh J; Gafter U
    Am J Kidney Dis; 1999 Jan; 33(1):82-6. PubMed ID: 9915271
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Chronic kidney disease (CKD) and bone. Management of chronic kidney disease-mineral and bone disorder in peritoneal dialysis patients].
    Yaginuma T; Yamamoto H
    Clin Calcium; 2009 Apr; 19(4):508-13. PubMed ID: 19329829
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Changes in selected parameters of bone turnover resulting from use of different calcium concentrations in dialysate of patients treated with CAPD].
    Orłowska-Kowalik G; Majdan M; Grzebalska A; Ksiazek A
    Pol Arch Med Wewn; 2004 Jul; 112(1):811-5. PubMed ID: 15526841
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Transperitoneal calcium mass transfer using dialysate with a low calcium concentration (1.0 mM).
    Weinreich T; Colombi A; Echterhoff HH; Mielke G; Nebel M; Ziegelmayer C; Passlick-Deetjen J
    Perit Dial Int; 1993; 13 Suppl 2():S467-70. PubMed ID: 8399641
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Renal osteodystrophy in dialysis patients: diagnosis and treatment.
    Fournier A; Oprisiu R; Hottelart C; Yverneau PH; Ghazali A; Atik A; Hedri H; Said S; Sechet A; Rasolombololona M; Abighanem O; Sarraj A; El Esper N; Moriniere P; Boudailliez B; Westeel PF; Achard JM; Pruna A
    Artif Organs; 1998 Jul; 22(7):530-57. PubMed ID: 9684690
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dialysate calcium reduction in CAPD patients treated with calcium carbonate and alfacalcidol.
    Cunningham J; Beer J; Coldwell RD; Noonan K; Sawyer N; Makin HL
    Nephrol Dial Transplant; 1992; 7(1):63-8. PubMed ID: 1316583
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.